Cargando…
Study protocol for the COPE study: COVID-19 in Older PEople: the influence of frailty and multimorbidity on survival. A multicentre, European observational study
INTRODUCTION: This protocol describes an observational study which set out to assess whether frailty and/or multimorbidity correlates with short-term and medium-term outcomes in patients diagnosed with COVID-19 in a European, multicentre setting. METHODS AND ANALYSIS: Over a 3-month period we aim to...
Autores principales: | Price, Angeline, Barlow-Pay, Fenella, Duffy, Siobhan, Pearce, Lyndsay, Vilches-Moraga, Arturo, Moug, Susan, Quinn, Terry, Stechman, Michael, Braude, Philip, Mitchell, Emma, Myint, Phyo Kyaw, Verduri, Alessia, McCarthy, Kathryn, Carter, Ben, Hewitt, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526029/ https://www.ncbi.nlm.nih.gov/pubmed/32994260 http://dx.doi.org/10.1136/bmjopen-2020-040569 |
Ejemplares similares
-
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study
por: Hewitt, Jonathan, et al.
Publicado: (2020) -
Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19
por: Bruce, Eilidh, et al.
Publicado: (2020) -
The Clinical Frailty Scale: Estimating the Prevalence of Frailty in Older Patients Hospitalised with COVID-19. The COPE Study
por: Collins, Jemima T., et al.
Publicado: (2020) -
The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
por: Braude, Philip, et al.
Publicado: (2020) -
The role of C-reactive protein as a prognostic marker in COVID-19
por: Stringer, Dominic, et al.
Publicado: (2021)